Physician profile
Michael W Cantrell
NPI 1184672453
$8,552.02
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2022: $3,779 · 2023: $3,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,625 · Food and Beverage: $15.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,625.00 |
| Food and Beverage | $15.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tigon Medical LLC | $3,625.00 | 2023 | |
| Smith+Nephew, INC. | $2,554.22 | 2022 | |
| Prime Surgical, LLC | $1,200.00 | 2022 | |
| Trice Medical, INC. | $1,157.76 | 2019-2022 | |
| Boston Scientific Corporation | $15.04 | 2023 | Spectra Wavewriter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$417,002.78 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cantrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.